Thomas Walters, MD
Ophthalmology · Austin, TXNPI 1609852664
Payments from drug & device makers
Across 579 payments — averaging $4112.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.6M
- Alcon Research LLC$345K
- Ocular Therapeutix, Inc.$290K
- Shire North American Group Inc$44K
- Sun Pharmaceutical Industries Inc.$43K
- Aerie Pharmaceuticals, Inc.$30K
- plus $16K from 13 others
Across 18 payments — averaging $1469.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$22K
- AbbVie$3K
- Ocular Therapeutix, Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 231 | $1,612,983 |
| Alcon Research LLC | 225 | $345,072 |
| Ocular Therapeutix, Inc. | 26 | $289,991 |
| Shire North American Group Inc | 1 | $44,371 |
| Sun Pharmaceutical Industries Inc. | 12 | $43,380 |
| Aerie Pharmaceuticals, Inc. | 5 | $29,591 |
| Ivantis, Inc | 3 | $7,540 |
| Osmotica Pharmaceutical Corp. | 2 | $3,969 |
| Alcon | 45 | $2,532 |
| Carl Zeiss Meditec USA, Inc. | 6 | $510 |
| Rxsight Inc | 6 | $497 |
| Carl Zeiss Meditec, Inc. | 3 | $387 |
| Biotissue Holdings Inc. | 4 | $150 |
| Bausch & Lomb Americas Inc. | 1 | $125 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $65 |
| Tearlab Corp | 3 | $63 |
| Glaukos Corporation | 1 | $29 |
| Rayner Intraocular Lenses Limited | 1 | $23 |
| Novartis | 1 | $18 |
How this compares
$2,381,294 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Austin
- Chirag JhaveriAustin$9.4M
- Robert WongAustin$6.6M
- Fuad MakkoukAustin$6.6M
- Shelley GhafooriAustin$2.9M
- Philip StoreyAustin$2.1M
- Saradha ChexalAustin$1.8M
- James DoonerAustin$556K
- Charles WykoffBellaire$73.4M
- David BrownHouston$51.7M
- Sunil PatelAbilene$11.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.